Trial Profile
A Phase I Randomized Open-Label Study Evaluating Safety, Tolerability And Pharmacokinetics Of Intravenous Hemoporfin In Healthy Chinese Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Hematoporphyrin monomethyl ether (Primary)
- Indications Port-wine stain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 09 Mar 2017 New trial record